Vir Biotechnology, Inc. — Director's Dealing 2019

Oct 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2019-10-16

Reporting Person: Frueh Klaus (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-16	Common Stock	C	218400	—	Acquired	362844	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-16	Series A-2 Convertible Preferred Stock	$	C	218400	Disposed		Common Stock (218400)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	77777	Direct

Footnotes

F1: Each share of the Issuer's Series A-2 Convertible Preferred Stock (the "Preferred Stock") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.

F2: The shares are held in the name of the Klaus and Renate Frueh Revocable Trust Dated June 26, 2017.